Dahl Dahl D D Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial JAMA JAMA 2022 2022 327 327 6 6 534 534 545 545 10.1001/jama.2022.0078 10.1001/jama.2022.0078 supplied-pmid 35133415? This evidence concerns the gene INS and type 2 diabetes mellitus.